JPMA Exec Raps Off-Year Re-Pricing Plan, Says It Significantly Mars Predictability

JPMA Director General Junichi Shiraishi Junichi Shiraishi, director general of the Japan Pharmaceutical Manufacturers Association (JPMA), on January 21 aired his grievances over the government’s decision to cover a wide range of drugs in its first “off-year” re-pricing this April,...read more